Kyn Therapeutics announced the appointments of Ronald Renaud as chairman of its board of directors and Francisco Quintana, Ph.D., as a new member of company’s scientific advisory board. Mr. Renaud currently serves as the chief executive officer of Translate Bio. Formerly, he served as president and chief executive officer at Idenix Pharmaceuticals until its acquisition by Merck in August 2014. Dr. Quintana is a highly-awarded immunologist and has published over 140 peer-reviewed articles and book chapters.